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Prostacyclin and other related compounds known to increase intracellular cAMP levels inhibit platelet re- 
sponses. The mechanisms involved are only partially known, especially those concerning the complex rela- 
tions between Ca 2 ÷ and cAMP as opposite intracellular mediators. Here, we have investigated aggregation 
and secretion i  quin2-1oaded platelets under conditions in which Ca 2 ÷ and cAMP are the only intracellular 
mediators. Our results how that cAMP inhibits aggregation a d secretion i  ionophore-treated c llwithout 
modifying their intracellular Ca 2 + levels. This result suggests that the inhibition takes place on some intra- 
cellular target for Ca 2 +. 
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1. INTRODUCTION 
The rise of cytoplasmic Ca 2+ levels is probably 
the main trigger of platelet exocytotic secretion 
even though other messengers such as thrombox- 
anes and DAG are also involved in physiological 
responses [1]. cAMP acts as a negative modulator 
by inhibiting key regulatory enzymes like 
phospholipases C and A2, cyclo-oxygenase and 
thromboxane synthetase [2]. However, the effect 
of cAMP on intracellular Ca 2÷ homeostasis re- 
mains not well defined. 
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We report here the results of experiments in 
which the Ca 2+ ionophore ionomycin was used to 
activate aggregation and exocytotic secretion in 
human platelets treated with aspirin. Under these 
conditions Ca 2+ is the only possible intracellular 
trigger, since the thromboxane pathway has been 
inhibited and phosphatidylinositol turnover is 
negligible in ionophore-treated cells [3]. Forskolin, 
an agent known to raise intracellular cAMP levels 
by direct stimulation of adenylate cyclase [4], was 
used to determine whether cAMP exerts its action 
by modifying the cytoplasmic Ca 2+ rise induced by 
the ionophore treatment or by affecting subse- 
quent steps of the CaZ÷-transducing mechanism. 
2. EXPERIMENTAL 
Platelet-rich plasma (PRP) was obtained by cen- 
trifugation of freshly drawn blood, anticoagulated 
with acid-citrate-dextrose (ACD), for 5 min at 
800 x g [5]. Cells were loaded with the fluorescent 
Ca z+ indicator quin2 by incubation of PRP with 
15/zM quin2 acetoxy methyl ester for 30 min at 
37°C. The platelets were then centrifuged at 350 x 
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g for 20 min and resuspended in a medium con- 
taining (mM): 150 NaC1, 5 KCI, 1 MgCI2, I0 
glucose, 10 Na-Hepes, pH 7.40. Thromboxane 
synthesis was blocked by incubating this suspen- 
sion for 10 min at 37°C in the presence of 100#M 
aspirin. 
Aggregation was followed in a Payton ag- 
gregometer under continuous stirring [6]. Cells 
were first incubated for 1 min in medium contain- 
ing 1 mM Ca z÷. Ionophore was then added and, 
after a fixed period of 3 min, samples of the cell 
suspension were centrifuged and the secreted ATP 
was measured in the supernatant solution [7]. 
Quin2 fluorescence was monitored in parallel ex- 
periments in a Perkin Elmer 204 spec- 
trofluorimeter with monochromators set at 
340 nm excitation and 500 nm emission. In- 
tracellular Ca 2+ values were calculated using the 
general formula: 
[Ca z+] = Kd(F -  Fmin)/(Fmax -- F) 
A value of 116 nM was used for Kd [8]. Frna× was 
obtained by adding to the cell suspension 400 nM 
ionomycin, a concentration known to give max- 
imal effect. Fmin  was  calculated as one-sixth of the 
difference between Fmax and cell autofluorescence, 
which was estimated after addition of 2 mM 
MnCI2 to quench the quin2 fluorescence [9]. The 
final concentration of quin2 in the cell water was 
always between 1 and 2 mM. 
Intracellular cAMP levels were raised by a 2 rain 
incubation with 20#M forskolin plus 20FM 
IBMX, a stimulator of adenylate cyclase and an in- 
hibitor of phosphodiesterase, r spectively, cAMP 
levels, measured by a specific radioimmunoassay 
(Amersham), were increased by this treatment 
from 1.79 + 0.61 to 50.80 + 10.79 pmol/108 ceils 
(mean _+ SE). It was also checked that the 
treatments with forskolin and ionophore did not 
produce non-specific membrane permeabilization, 
as shown by the fact that over 90070 of LDH activi- 
ty (Boehringer Mannheim Monotest) was retained 
by treated cells by the end of the incubation 
period. 
All chemicals were obtained from Sigma except 
forskolin (Calbiochem), quin2 (a kind gift from Dr 
T.J. Rink, Smith Kline-French, London) and 
ionomycin (a personal gift from Dr V.L. Lew, 
Physiological Laboratory, Cambridge). All drugs 
were added to cell suspensions from concentrated 
solutions in ethanol (ionomycin, forskolin and 
IBMX), DMSO (quin2 acetoxymethyl ester) or 
buffer. The final concentration of organic solvent 
was always below 0.5%. 
3. RESULTS AND DISCUSSION 
Fig.1 shows simultaneous measurements of ab- 
sorbance (A), ATP release (B) and fluorescence of 
quin2-1oaded cells (C), in either control (top) or 
forskolin-treated cells (bottom). Forskolin treat- 
ment did not change the intracellular resting Ca 2÷ 
level, which was maintained around 70 nM under 
both conditions (fig.lC). This result suggests that 
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Fig. 1. (A) Two sets of absorbance records in 
quin2-1oaded platelets uspended in the usual medium 
containing 100 #M aspirin and 1 mM CaCI2, in control 
cells (top) or 2 min after addition of 20#M forskolin 
plus 20#M IBMX (bottom). Experiments were 
performed at 37°C and under continuous tirring. One 
typical experiment representative of 3 similar ones is 
shown. (B) Histogram of means _+ SE (3 experiments) of
secreted ATP, measured in samples taken from the 
aggregometer cuvette whose records are shown in panel 
A. The values are expressed as  percentage of the 
maximal releasable pool, which was estimated from the 
response to 0.5 U/ml thrombin. Secretion of serotonin 
was also measured in a single xperiment which gave 
similar results to those shown in this panel. (C) Two sets 
of records showing changes in the fluorescence of 
quin2-1oaded cells. Measurements were preformed in 
parallel with the records of absorbance shown in panel 
A, and under the same experimental conditions. 
Calibration of the signal was made as specified in section 
2. One typical experiment representative of 3 similar 
ones is shown. 
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cAMP does not lower the resting intracellular Ca 2+ 
concentration by stimulation of mechanisms such 
as Ca 2+ extrusion or Ca 2+ sequestration in in- 
tracellular compartments, asproposed in [10]. In- 
creasing concentrations of the Ca z+ ionophore 
ionomycin produced cells with progressively in- 
creased levels of Ca 2+ which were maintained at a 
steady level for at least 3 min after stimulation. 
The recordings of quin2 fluorescence after six dif- 
ferent ionomycin additions to either control or 
forskolin-treated cells were practically identical 
under both conditions, indicating that, at least 
during the period under study, elevated in- 
tracellular cAMP levels did not interfere with Ca 2+ 
homeostasis. This result contrasts with previous 
reports, in which forskolin treatment completely 
abolished the intracellular Ca 2+ rise induced by 
thrombin, collagen [11] or PAF [12]. This dif- 
ference suggests that cAMP affects only the Ca 2+ 
entry and release mediated by receptor-operated 
mechanisms and not by an artificial increase of 
Ca z+ permeability. 
Aggregation and secretion of forskolin-treated 
cells were consistently lower than those of control 
cells (fig.lA,B). Since, as discussed before, Ca 2+ 
levels were similar under both conditions, the in- 
hibition could be interpreted as meaning that 
cAMP interferes with the generation of other in- 
tracellular mediators. DAG or thromboxanes 
would be likely candidates but, as mentioned in 
section 1, they play a negligible role under our ex- 
perimental conditions. An alternative xplanation 
would be that cAMP interferes with the action of 
Ca 2+ on the secretion and aggregation machinery. 
In fig.2 we have plotted the percentage of 
secretory effect vs intracellular Ca z+ levels in con- 
trol and forskolin-treated cells, cAMP decreased 
the effect obtained at the highest intracellular Ca z+ 
concentration tested (-3/~M). On the other hand, 
the Es0 value for Ca 2+ was increased in the 
forskolin-treated preparation (900 vs 700 nM in 
the corresponding controls). These results are in 
apparent contrast with previous work [13], in 
which 20/~M cAMP did not affect the Ca 2+ dose- 
response curves for serotonin secretion in high- 
voltage-permeabilized cells. However, the same 
authors have reported that 100/~M cAMP in- 
hibited serotonin secretion induced by TPA or 
OAG, two direct activators of protein kinase C 
[14], in the same preparation [15]. In the light of 
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Fig.2. Secretion of ATP by quin2-1oaded platelets as a 
function of intracellular Ca 2+ concentration i control 
(o) and forskolin-treated cells (o). Note the logarithmic 
scale for Ca z+ concentration. Experimental conditions 
as in fig.1. Means _+ SE of 3 experiments are shown. 
the above findings, our results could be interpreted 
as indicating that, in our intact preparation, in- 
tracellular cAMP acts by lowering the Ca z+ affini- 
ty of protein kinase C, a key enzyme in the 
transduction of the secretory message [14]. Other 
possible actions responsible for the decrease in 
maximal effects of Ca z+ on ATP secretion cannot 
be discounted. 
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